Edgewise Therapeutics, Inc.
EWTX
$29.69
-$0.81-2.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.75% | 14.38% | 16.07% | -18.09% | 47.67% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 149.88% | 53.04% | 20.46% | -21.65% | -38.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.28% | 14.91% | 16.14% | -18.15% | 45.41% |
|
|
|||||
| Total Current Assets | 14.28% | 14.91% | 16.14% | -18.15% | 45.41% |
| Net Property, Plant & Equipment | -16.74% | -17.42% | -15.61% | -15.03% | -12.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -24.71% |
| Total Assets | 13.51% | 14.12% | 15.36% | -17.95% | 43.17% |
|
|
|||||
| Total Accounts Payable | 7.65% | 8.99% | 22.33% | 86.09% | 38.61% |
| Total Accrued Expenses | 17.73% | 17.58% | 23.28% | 27.35% | 46.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.81% | 1.61% | 1.62% | 1.73% | 1.63% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 14.71% | 14.18% | 21.66% | 44.62% | 42.27% |
|
|
|||||
| Total Current Liabilities | 14.71% | 14.18% | 21.66% | 44.62% | 42.27% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.45% | -7.98% | -15.76% | -16.60% | -15.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.95% | 10.77% | 14.59% | 30.78% | 30.16% |
|
|
|||||
| Common Stock & APIC | 27.54% | 27.50% | 27.94% | 4.89% | 48.60% |
| Retained Earnings | -44.32% | -46.40% | -49.45% | -53.45% | -54.67% |
| Treasury Stock & Other | 61.19% | -33.30% | 119.35% | 146.57% | 324.24% |
| Total Common Equity | 13.73% | 14.27% | 15.40% | -19.67% | 44.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.73% | 14.27% | 15.40% | -19.67% | 44.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.73% | 14.27% | 15.40% | -19.67% | 44.03% |
|
|
|||||